Cytodyn, Inc.

This study tested an experimental drug called PRO 140, given as a shot, in combination with other HIV medications. It was for adults whose current HIV drugs were no longer working well due to the virus becoming resistant. The main goal was to see if this new combination could saf…

This study tested an experimental drug called leronlimab in patients with advanced solid tumors that had stopped responding to standard treatments. Sixteen participants received weekly injections of leronlimab, often alongside their regular chemotherapy or radiation. Researchers …

This study tested whether a weekly injection called leronlimab could help people hospitalized with severe or critical COVID-19. Nearly 500 participants were randomly assigned to receive either the drug or a placebo shot. Researchers measured if the treatment reduced deaths and he…

This study tested if a weekly injection called PRO 140 could control HIV by itself for 48 weeks, instead of the standard daily pill combinations. It involved 562 adults whose HIV was already well-controlled on daily medications. The goal was to see if switching to just the weekly…